The Pharmacological Effects of Novokinin; a Designed Peptide Agonist of the Angiotensin AT2 Receptor
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3009-3012
Author(s):
Masaaki Yoshikawa, Kousaku Ohinata and Yuko Yamada
Gene Polymorphism of Angiotensin II Type 1 and Type 2 Receptors
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2996-3001
Author(s):
Tomohiro Katsuya and Ryuichi Morishita
Editorial(Angiotensin II Receptor Research)
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2979-2980
Author(s):
Shin-ichiro Miura
Regulation of Angiotensin II Receptor Expression
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3013-3021
Author(s):
Toshihiro Ichiki
Redox Control of Cardiovascular Homeostasis by Angiotensin II
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3022-3032
Author(s):
Caroline Sunggip, Naoyuki Kitajima and Motohiro Nishida
Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3049-3053
Author(s):
Hironori Nakagami, Mariana Kiomy Osako and Ryuichi Morishita
The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3094-3106
Author(s):
Ioanna Gouni-Berthold and Heiner K. Berthold
Invasive Aspergillosis in Children and Adolescents
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3545-3568
Author(s):
Andreas H. Groll, Dominik Schrey, Athanasios Tragiannidis, Konrad Bochennek and Thomas Lehrnbecher
Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
13
Page:
997-1004
Author(s):
Daniel Fábio Kawano and Ivone Carvalho
Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3569-3594
Author(s):
Meinolf Karthaus and Dieter Buchheidt